...
首页> 外文期刊>ASAIO journal >Monitoring Volume Status Using Bioelectrical Impedance Analysis in Chronic Hemodialysis Patients
【24h】

Monitoring Volume Status Using Bioelectrical Impedance Analysis in Chronic Hemodialysis Patients

机译:在慢性血液透析患者中使用生物电阻抗分析监测体积状态

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Fluid overload can be an independent risk factor of cardiovascular events and all-cause death in end-stage renal disease (ESRD) patients on chronic hemodialysis. We performed a retrospective study to investigate whether intermittent control of fluid status decreases the rate of these complications using bioelectrical impedance analysis (BIA). In ESRD patients on chronic hemodialysis, we identified the ratio of extracellular water to total body water (ECW/TBW) every 6 months using InBody S10 (Biospace, Seoul, Korea), which was measured within 30 minutes after dialysis initiation on the first dialysis day of the week. The uncontrolled group included 57 (40.1%) patients with all ECW/TBW measurements 0.40; in contrast, the controlled group included 85 (59.9%) with any measured ECW/TBW 0.40. Included patients were followed for 29 (12-42) months. The risk of cardiovascular events was higher in the uncontrolled group (hazard ratio [HR], 2.4; 95% confidence interval [CI], 1.2-5.1; p 0.05) than it was in the controlled group; however, this difference disappeared after adjusting for age, sex, and Charlson comorbidity index (not significant). On the other hand, the patients in the uncontrolled group had a higher risk of all-cause death than did those in the controlled group, independent of age, sex, and Charlson comorbidity index (HR, 4.7; 95% CI, 1.4-16.1; p 0.05). In conclusion, monitoring volume status using BIA may help to predict all-cause death in chronic hemodialysis patients. Further controlled studies are needed to confirm that strict volume control could reduce the rates of cardiovascular events and mortality in this population.
机译:流体过载可以是心血管事件的独立危险因素,并在慢性血液透析患者患者终末期肾病(ESRD)患者中的全因危险因素。我们进行了回顾性研究以研究流体状态的间歇控制是否会使用生物电阻抗分析(BIA)降低这些并发症的速率。在ESRD患者慢性血液透析患者中​​,我们使用体内S10(Biospace,Seoul,Korea)确定了细胞外水与总体水中的总体水(ECW / TBW)的比例,所述透析在透析在第一个透析后30分钟内测量。一周中的天。不受控制的组包括57名(40.1%)患者,所有ECW / TBW测量0.40;相反,受控组包含85(59.9%),任何测量的ECW / TBW <0.40。包括患者29(12-42)个月。不受控制的组(危害比[HR],2.4; 95%置信区间[CI],1.2-5.1; P <0.05)中的心血管事件的风险高于受控组;然而,在调整年龄,性别和查理合并症指数(不显着)后,这种差异消失了。另一方面,不受控制的组患者的患者患有较高的危险性死亡的风险较高,而不是受控组中的那些,无关,独立于年龄,性别和查尔森合并症指数(HR,4.7; 95%CI,1.4-16.1 ; P <0.05)。总之,使用BIA的监测体积状态可能有助于预测慢性血液透析患者的全因死死亡。需要进一步受控研究以确认严格的体积控制可以降低该人群的心血管事件和死亡率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号